Association of serum phosphate levels and statin use with cardiovascular events in Japanese patients on chronic haemodialysis: a post-hoc analysis of the LANDMARK trial
Time-dependent statin use was associated with a lower risk of all-cause death. However, statin and serum phosphate levels were not significantly associated with lower risk of CVEs or mortality.
Authors
- Masahide Mizobuchi (ORCID: https://orcid.org/0000-0002-6117-8414)
- Etsuro Ogata (ORCID: https://orcid.org/0000-0002-0046-5575)
- Akane Yamakawa (ORCID: https://orcid.org/0000-0002-8679-9014)
- Tatsuo Kagimura (ORCID: https://orcid.org/0000-0001-9856-1006)
- Tomohiro Saito (ORCID: https://orcid.org/0000-0003-2303-5401)
- Tadao Akizawa (ORCID: https://orcid.org/0000-0002-6150-9201)
- Hirokazu Honda (ORCID: https://orcid.org/0000-0002-5634-6145)
- Masafumi Fukagawa (ORCID: https://orcid.org/0000-0002-7832-2339)
- Hideki Hirakata
Institutions
- Foundation for Biomedical Research (US)
- Tokai University (JP)
- SHOWA Medical University Northern Yokohama Hospital (JP)
- Saiseikai Fukuoka General Hospital (JP)
- SHOWA Medical University Fujigaoka Hospital (JP)
- Foundation for Biomedical Research and Innovation (JP)
Publication Details
- Journal
- Clinical Kidney Journal
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1093/ckj/sfaf151
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Foundation for Biomedical Research and Innovation
- Bayer Yakuhin
- Japan Society for the Promotion of Science